Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Skin sensitisation (in vivo; GPMT); Not sensitising (OECD 406)

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin sensitisation: in vitro
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
an in vitro skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study are available
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
other: SNIF
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
All information in this endpoint has been provided by the ECHA using the 12-year rule, this is data not owned by the registrant. The reliability is assumed to be at level 2. Therefore the following reliability statement can be used: Study conducted in accordance with generally accepted scientific principles, possibly with incorect reporting or methodological deficiencies, which do not affect the quality of the relevant results.
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
GLP compliance:
not specified
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
All information in this endpoint has been provided by the ECHA using the 12-year rule.
Species:
guinea pig
Strain:
other: Hartley/Dunkin
Sex:
female
Route:
intradermal
Vehicle:
other: liquid paraffin
Concentration / amount:
1%
Day(s)/duration:
Day 0
Adequacy of induction:
other: no irritation noted
Route:
other: dermal
Vehicle:
other: liquid paraffin
Concentration / amount:
50%
Day(s)/duration:
Day 7
Adequacy of induction:
other: no irritation noted
No.:
#1
Route:
other: not stated
Vehicle:
other: liquid paraffin
Concentration / amount:
25%
Day(s)/duration:
48 hrs
Adequacy of challenge:
not specified
No.:
#2
Route:
other: not stated
Vehicle:
other: liquid paraffin
Concentration / amount:
50%
Day(s)/duration:
48 hrs
Adequacy of challenge:
not specified
No. of animals per dose:
20 test group
20 controls
Positive control substance(s):
no
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
25%
No. with + reactions:
4
Total no. in group:
20
Reading:
1st reading
Hours after challenge:
48
Group:
negative control
Dose level:
25%
No. with + reactions:
2
Total no. in group:
19
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50%
No. with + reactions:
5
Total no. in group:
20
Reading:
1st reading
Hours after challenge:
48
Group:
negative control
Dose level:
50%
No. with + reactions:
4
Total no. in group:
19

Other observations:

In a preliminary study, dermal application at 10-50% w/w in liquid paraffin did not cause any skin reactions. At challenge only slight erythema was seen in all animals that showed a skin reaction; scores in test animals did not exceed those in controls. One control animal died prior to challenge (death not treatment-related).

Interpretation of results:
GHS criteria not met
Conclusions:
In an in vivo skin sensitisation (GPMT), the substance is not sensitising.
Executive summary:

In a dermal sensitization study (OECD 406) with DL-N33 in paraffin oil, Hartley/Dunkin female guinea pigs were tested in a maximisation test. For induction, 1% DL-N33 in paraffin oil (intradermal injections) and 50% DL-N33 in paraffin oil (dermal) was used. For challenge, 25% and 50% DL-N33 in paraffin oil was used. The evaluation of skin reactions after challenge was carried out at 48 hrs.

In the preliminary study, dermal application at 10-50% w/w in liquid paraffin did not cause any skin reactions. One control animal died prior to challenge in the main study (death not treatment-related). In the main study at 25%, 4/20 test group animals and 2/19 control animals were positive. At 50%, 5/20 test group animals and 4/19 control animals were positive. At challenge, only slight erythema was seen in all animals that showed a skin reaction. The substance is not sensitising.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

There is no in vitro skin sensitisation data available. One in vivo skin sensitisation (GPMT) is available.

In a dermal sensitization study (OECD 406) with DL-N33 in paraffin oil, Hartley/Dunkin female guinea pigs were tested in a maximisation test. For induction, 1% DL-N33 in paraffin oil (intradermal injections) and 50% DL-N33 in paraffin oil (dermal) was used. For challenge, 25% and 50% DL-N33 in paraffin oil was used. The evaluation of skin reactions after challenge was carried out at 48 hrs. No positive control substance was used. In a preliminary study, dermal application at 10-50% w/w in liquid paraffin did not cause any skin reactions. One control animal died prior to challenge in the main study (death not treatment-related). In the main study at 25%, 4/20 test group animals and 2/19 control animals were positive. At 50%, 5/20 test group animals and 4/19 control animals were positive. At challenge, only slight erythema was seen in all animals that showed a skin reaction. The substance is not sensitising.

The data is acceptable to use in the human health risk assessment.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Based on the available information in the dossier, the substance DL-N33 (CAS No. 104815-18-1) does not need to be classified for skin sensitisation when the criteria outlined in Annex I of 1272/2008/EC and Annex I of 286/2011/EC are applied.